These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33199862)

  • 21. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Microbes Infect; 2000 May; 2(6):659-69. PubMed ID: 10884617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
    Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips.
    Fu LM; Shinnick TM
    Tuberculosis (Edinb); 2007 Jan; 87(1):63-70. PubMed ID: 16890025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of isoniazid killing: clarity through the scope of genetics.
    Vilchèze C; Jacobs WR
    Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
    Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
    Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.
    Dhar N; McKinney JD
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12275-80. PubMed ID: 20566858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.
    Dhandayuthapani S; Zhang Y; Mudd MH; Deretic V
    J Bacteriol; 1996 Jun; 178(12):3641-9. PubMed ID: 8655566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis.
    Siddiqi S; Takhar P; Baldeviano C; Glover W; Zhang Y
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2100-4. PubMed ID: 17438054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
    Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
    J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
    Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.
    Sreevatsan S; Pan X; Zhang Y; Deretic V; Musser JM
    Antimicrob Agents Chemother; 1997 Mar; 41(3):600-6. PubMed ID: 9056000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips.
    Fu LM
    Tuberculosis (Edinb); 2006 Mar; 86(2):134-43. PubMed ID: 16246625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of Rv0559c and Rv0560c expression in drug-resistant Mycobacterium tuberculosis in response to first-line antituberculosis drugs.
    Gamngoen R; Putim C; Salee P; Phunpae P; Butr-Indr B
    Tuberculosis (Edinb); 2018 Jan; 108():64-69. PubMed ID: 29523329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic and morphological changes produced by subinhibitory concentration of isoniazid in Mycobacterium tuberculosis.
    Campanerut-Sá PA; Ghiraldi-Lopes LD; Meneguello JE; Fiorini A; Evaristo GP; Siqueira VL; Scodro RB; Patussi EV; Donatti L; Souza EM; Cardoso RF
    Future Microbiol; 2016 Sep; 11():1123-32. PubMed ID: 27545345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.